Riskpilot← Back to searchSign inGet full accessCELLDOS AB
ABActiveOrg 5569388779Västbergavägen 25Accounting, bookkeeping and auditing activities; tax consultancy · NACE 6920Est. 20130 employees
Revenue 2025
SEK 0
EBITDA margin
—
+36% vs 2024
Equity ratio
53.8%
Financial strength
Net profit 2025
SEK -73K
+36% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -72K | +36% |
| Net profit | SEK -73K | +36% |
| Total assets | SEK 2,7M | -7% |
| Equity | SEK 1,5M | -5% |
| Employees | 0 | — |
Legal name
CELLDOS AB
Org number
5569388779
Legal form
Aktiebolag
NACE code
6920 · Accounting, bookkeeping and auditing activities; tax consultancy
Founded
9 augusti 2013
Share capital
SEK 55 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva utredningar, analyser, redovisning, rådgivning och konsultation inom ekonomi.
Address
Västbergavägen 25
Phone
+46843737549
Email
ekonomi@liliumab.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 608 | 198 | 0 | 0 | 0 |
| Staff expenses | — | −122 | −0 | — | — |
| EBITDA | 34 | 56 | −7 | −112 | −72 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 34 | 56 | −7 | −112 | −72 |
| Net financials | — | −1 | −2 | −1 | −1 |
| Profit before tax | 34 | 55 | −9 | −113 | −73 |
| Tax | −6 | −13 | — | — | — |
| Net profit | 28 | 43 | −9 | −113 | −73 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 772 | 3 125 | 3 124 | 2 921 | 2 713 |
| Equity | 1 610 | 1 652 | 1 644 | 1 531 | 1 458 |
| Long-term debt | 0 | — | — | — | 5 |
| Short-term debt | 162 | 1 472 | 1 480 | 1 390 | 1 250 |
| Total debt | 162 | 1 472 | 1 480 | 1 390 | 1 254 |
EBITDA margin
-7168700.0%
This company
15.8%
Market median
-45371619% vs market
20212025
Equity ratio
53.8%
This company
38.2%
Market median
+41% vs market
20212025
Return on equity
-5.0%
This company
18.4%
Market median
-127% vs market
20212025
Net profit margin
-7255900.0%
This company
8.1%
Market median
-89579112% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2023 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CELLDOS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kimmy Carl Adam Pilo | Board of Directors | 0 companies |
| Andreas Tommy Ehn | Board of Directors | 0 companies |
| Suzana Karlsson | Deputy Board Member | 0 companies |
| Taarek Wattad | Board of Directors | 0 companies |